Type II Diabetes Mellitus Clinical Trial
— Care4LifeOfficial title:
Use of Mobile Health Technology as an Intervention for Type II Diabetes Self-Management
Verified date | September 2012 |
Source | HealthInsight |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
This purpose of this is study is to evaluate the effectiveness of an interactive mobile health information service, Care4Life, in supporting patient self-management of Type II Diabetes Mellitus.
Status | Enrolling by invitation |
Enrollment | 500 |
Est. completion date | February 2013 |
Est. primary completion date | December 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Laboratory test for HbA1c = 8% within the past year - Clinical diagnosis of DM - Age > 18 years old - Patient in a Beacon clinic - Cell phone ownership or willingness to acquire a cell phone capable of receiving and sending SMS messages - Women who are not pregnant Exclusion Criteria: - Failure to meet inclusion criteria |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
United States | Coalville Health Center | Coalville | Utah |
United States | Pioneer Comprehensive Medical | Draper | Utah |
United States | Holladay Family Practice | Holladay | Utah |
United States | Olympus Clinic | Holladay | Utah |
United States | Exodus Healthcare - Main Office - Magna | Magna | Utah |
United States | Community Health Centers Inc. - 72nd Street Clinic | Midvale | Utah |
United States | Park City Healthcare, Inc. | Park City | Utah |
United States | Granger Medical-Riverton | Riverton | Utah |
United States | Riverton Family Health Center | Riverton | Utah |
United States | Alpine Internal Medicine | Salt Lake City | Utah |
United States | Central City Community Health Center Health First Family Medicine | Salt Lake City | Utah |
United States | Evolutionary Healthcare, Llc | Salt Lake City | Utah |
United States | Health Clinic Of Utah - SLC | Salt Lake City | Utah |
United States | HealthInsight | Salt Lake City | Utah |
United States | Jordan Ridge Family Medicine | Salt Lake City | Utah |
United States | Stephen D. Ratcliffe Community Health Center | Salt Lake City | Utah |
United States | Utah Healthcare Institute - St. Mark's Family Medicine | Salt Lake City | Utah |
United States | Utah Physicians Care Centers - St Mark's Internal Medicine | Salt Lake City | Utah |
United States | Wasatch Homeless Health Care - 4th Street Clinic | Salt Lake City | Utah |
United States | Wasatch Internal Medicine | Salt Lake City | Utah |
United States | Barbara E. Rizzardi, M.D. | Sandy | Utah |
United States | Copperview Medical Center, Llc | South Jordan | Utah |
United States | Community Health Centers Inc. - Oquirrh View | Taylorsville | Utah |
United States | Advanced Practice Medical Clinic | Tooele | Utah |
United States | Valley Family Medicine | Tooele | Utah |
United States | Granger Medical - Jordan Medical Arts | West Jordan | Utah |
United States | Jordan Meadows Medical Center | West Jordan | Utah |
United States | Granger Medical Clinic Inc. - Main Office | West Valley City | Utah |
United States | Kathryn Allen, MD | West Valley City | Utah |
United States | West Valley Family And Preventive Medicine | West Valley City | Utah |
Lead Sponsor | Collaborator |
---|---|
HealthInsight | Center for Technology and Aging, Voxiva |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Hemoglobin A1c - In control, over time. | Hemoglobin A1c - In control as assessed by laboratory results of blood draw taken from patient's clinic. In control means a result of <9%. | 3, 6, 9, and 12 months | No |
Secondary | Change in Blood Pressure Control over time | Improved blood pressure (BP) control as demonstrated as BP = 140/90 millimeters mercury (mm Hg) | 3, 6, 9, 12 months | No |
Secondary | Change in BMI over time | Lower body mass index (BMI) among users of the SMS-based tool. | 3, 6, 9, 12 months | No |
Secondary | Disease Management | Improved knowledge of self-care and disease management practices among adult patients with diabetes treated in Beacon clinics in the Salt Lake Metropolitan Statistical Area (Salt Lake, Tooele, and Summit counties). | 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01952535 -
A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT01196728 -
Single-centre, Randomised, Double-blind, Placebo-controlled, Four-way Crossover Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Single Doses of CM3.1-AC100 in Patients With Type 2 Diabetes
|
Phase 1 | |
Terminated |
NCT00997152 -
Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients
|
Phase 2 | |
Completed |
NCT02592421 -
SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2
|
Phase 3 | |
Completed |
NCT05544214 -
Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01969084 -
The Effect of Linagliptin on Mitochondrial and Endothelial Function
|
Phase 4 | |
Terminated |
NCT01644201 -
A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics
|
Phase 3 | |
Completed |
NCT00995787 -
Safety and Tolerability of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Treated With Metformin and Sulfonylurea
|
Phase 1 | |
Completed |
NCT01020123 -
Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients
|
Phase 2 | |
Completed |
NCT01505426 -
A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients
|
Phase 3 | |
Completed |
NCT01262586 -
Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device.
|
Phase 3 | |
Completed |
NCT00561171 -
Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria
|
Phase 2 | |
Active, not recruiting |
NCT03912363 -
Intrapartum Glycemic Control With Insulin Infusion Versus Rotating Fluids
|
N/A | |
Completed |
NCT01868646 -
Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus
|
Phase 4 | |
Active, not recruiting |
NCT06386328 -
A Clinical Trial to Evaluate the Food Effect of CKD-378
|
Phase 1 | |
Terminated |
NCT02749435 -
A Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With Type 2 Diabetes Mellitus
|
N/A | |
Completed |
NCT00894868 -
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
|
Phase 4 | |
Recruiting |
NCT01165190 -
Effect of Pioglitazone on Mitochondrial Function in Muscle and Adipose Tissue in Humans
|
N/A | |
Completed |
NCT01255085 -
Yellow Pea Protein and Fibre and Short Term Food Intake
|
N/A | |
Completed |
NCT02156349 -
A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabetic Patients.
|
N/A |